RNS Number : 7942H
Cellular Goods PLC
01 August 2023
 

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014, as retained as part of the law of England and Wales. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

 

 

1 August 2023

 

Cellular Goods plc

 

("Cellular Goods" or "The Company")

 

Cellular Goods' products to launch in France and Germany

 

Cellular Goods (LSE: CBX) a UK-based wellness company providing premium consumer products formulated with lab-produced cannabinoids, is pleased to announce that products in its 'Look Better' (skincare) range will soon be available to purchase for the first time in France and Germany.

 

Cellular Goods will be opening sales from its ecommerce website for shipping to France and Germany from the Autumn, as we begin building momentum for the peak Christmas shopping period. The Company's products available for shipping to France and Germany will include the best-selling Rejuvenating Face Serum, Rejuvenating Night Cream and Nourishing Face Oil which are all powered by the company's hero breakthrough anti-inflammatory (CBG). CBG has been shown to prevent inflammation in the skin, known to accelerate skin ageing, without the side effects associated with industry-standard ingredients retinol and vitamin C.

 

Other products available for shipping to France and Germany will be the Company's SPF25 Rejuvenating Day Cream, Rejuvenating Day Mousse and Calming Cannabinoid After Shaving Moisturiser, as well as 'mini' sizes, which are designed to be compact and convenient for travel, and gifting ranges.

 

France is one of the largest Cannabinoid markets in the EU zone next to Germany, making them both core targets for our global distribution strategy following our launch in the USA in September 2022. The products will be available for shipping to French and German consumers via the Company's ecommerce website, www.cellular-goods.com, from the Autumn.

 

Darcy Taylor, Interim CEO, commented: "Cellular Goods is focused on continuing its expansion of the 'Look Better' skincare range into new markets and increasing global access to our products. Over the course of the next few months, we will be achieving another milestone in this strategy by opening our ecommerce site to our French and German customers. As the market for our 'Look Better' high-end skincare range experiences positive sales year on year, we want to continue expanding our distribution to deliver revenue growth and long-term shareholder value."

 

For further information please contact:

 

Cellular Goods


Darcy Taylor

Chairman and Interim CEO

via FSCF +44 7572 873 300

First Sentinel Corporate Finance (FSCF)


Investor Relations

Rebecca Noonan

IR@cellular-goods.com

Media Relations

Rebecca Noonan

Media@cellular-goods.com

Corporate Broker & Advisor

Brian Stockbridge

 

+44 7572 873 300

 

 

+44 7572 873 300

 

 

+44 7876 888 011

Novum Securities

 

Corporate Broker

Colin Rowbury

Jon Belliss

 

 

+44 207 399 9427 

 

About Cellular Goods PLC:

Cellular Goods is pioneering the use of lab-based and biosynthetic production methods for wellness and sustainability solutions. The Company launched with a focus on efficacy led and science-backed products utilising biosynthetics, and now employs its expertise across two verticals: premium next-generation cannabinoid skincare products, and carbon sequestration-as-a-service through its wholly owned business division, King Tide Carbon, which utilises biosynthetic algae and seaweed to provide scalable carbon removal. The Company is incorporated in the UK and listed on the Main Market of the London Stock Exchange. For more information, visit www.cellular-goods.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PRLEFLFXXDLEBBX